Intelligent Drug R‑D Services encompass AI‑enabled data analytics, predictive modeling, and digital platforms that accelerate target discovery, clinical trial design, and real‑world evidence generation for pharmaceutical innovators. These services are pivotal for shortening development cycles, reducing costs, and enhancing success rates in an increasingly data‑driven therapeutic landscape. The Intelligent Drug R‑D Services market size was estimated at $3.2 billion in 2025, and the market forecast projects a CAGR of 9.5% from 2026 to 2033, reflecting robust growth outlook driven by AI adoption, regulatory incentives for faster approvals, and rising demand for personalized medicines. The scope of this market spans AI‑driven target identification, clinical trial simulation, and real‑world evidence analytics across biotech, pharma, and contract research organizations.